Protocolo Clínico e Diretrizes Terapêuticas da esclerose múltipla

Secretaria de Ciência, Tecnologia e Insumos Estratégicos em Saúde (Brasil) em Saúde

Protocolo Clínico e Diretrizes Terapêuticas da esclerose múltipla / Clinical Protocol and Therapeutic Guidelines for Multiple Sclerosis

Secretaria de Ciência, Tecnologia e Insumos Estratégicos em Saúde (Brasil) em Saúde.

Brasília; CONITEC; nov. 2021.

Non-conventional in Portuguese | LILACS, ColecionaSUS | ID: biblio-1378387

Subject(s)

Multiple Sclerosis/diagnosis; Multiple Sclerosis/drug therapy; Multiple Sclerosis/therapy; Methylprednisolone/therapeutic use; Clinical Protocols/standards; Interferons/therapeutic use; Occupational Therapy/instrumentation; Physical Therapy Modalities; Speech, Language and Hearing Sciences/instrumentation; Fingolimod Hydrochloride/therapeutic use; Glatiramer Acetate/therapeutic use; Natalizumab/therapeutic use

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Multiple Sclerosis Type of study: Practice guideline Language: Portuguese Year: 2021 Type: Non-conventional

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Multiple Sclerosis Type of study: Practice guideline Language: Portuguese Year: 2021 Type: Non-conventional